Does recombinant Mouse β-Defensin 3 protect against Coxsackievirus B3-Induced Myocarditis in Mice?
rMBD3 was demonstrated to possess anti-CVB3 activity in vivo and in vitro.
EBV LMP1 mRNA transcriptional activity was observed in a significant proportion of CLL patients. Transcription of the EBV LMP1, a late gene with known transforming potential in vitro, suggests that EBV activation plays a role in CLL disease progression. Thus, EBV LMP1 expression in CLL patients may be a factor involved in the genesis of refractory disease.